Sign in
4

Changes in Ownership

Mereo BioPharma Group plc Filed Acc 0000950170-24-077487

Chief Scientific Officer acquired 69,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lewicki John A. · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-21 Exercise or conversion : show line 1 in the form +69,000 73,003 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-21 Exercise or conversion : show line 2 in the form Performance Based Restricted Stock Unit +69,000 46,000 D
Loading xslF345X05/ownership.xml…